Host Response Variability in Post-Tuberculosis Pulmonary Fibrosis and Related Structural and Functional Pulmonary Sequelae: A Scoping Review

Abstract Background Pulmonary fibrosis is among the most consequential forms of post-tuberculosis lung disease (PTLD), leaving permanent structural damage in people already cured of infection. Outcomes vary widely between individuals with comparable microbiological cure, and there is currently no way to predict who will develop fibrosis, prevent it, or treat its underlying biology. This scoping review mapped the evidence on host factors associated with variability in post-tuberculosis pulmonary fibrosis and related structural and functional sequelae. Methods Following PRISMA-ScR guidance, six databases were searched from inception to 31 August 2026. Studies of adults with treated pulmonary tuberculosis that examined host biological, molecular or clinical factors in relation to fibrotic, structural or functional outcomes were included. Two reviewers independently screened and appraised studies, and findings were charted against a predefined domain framework and an evidence gap map. Results Twenty studies were included, mostly observational and from high-burden settings. Evidence centred on clinical and radiological characterisation. Where biology was measured, persistent inflammation (IL-6, TNF-α) and matrix metalloproteinase activity were the most consistent signals associated with fibrotic and structural outcomes. Genetic, transcriptomic and metabolomic evidence was sparse, and no eligible study addressed epigenetic or microbiome factors. Conclusions Research on post-tuberculosis pulmonary fibrosis remains largely descriptive, and the critical gap is validated, targetable host biology. IL-6, TNF-α and matrix metalloproteinases are the strongest candidates and the priority for validation. Defining these pathways would open post-tuberculosis fibrosis to precision medicine, identifying survivors at risk early and treating them before irreversible damage is established.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11707370/v1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Host Response Variability in Post-Tuberculosis Pulmonary Fibrosis and Related Structural and Functional Pulmonary Sequelae: A Scoping Review

Arun Vamadevan, Lauren Elizabeth Walker, Vijesh Vijayan, Shahbaz Younas Choudary
2 links
Research Square
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
preprint

Host Response Variability in Post-Tuberculosis Pulmonary Fibrosis and Related Structural and Functional Pulmonary Sequelae: A Scoping Review

Arun Vamadevan, Lauren Elizabeth Walker, Vijesh Vijayan, Shahbaz Younas Choudary
preprint en

Abstract

Abstract Background Pulmonary fibrosis is among the most consequential forms of post-tuberculosis lung disease (PTLD), leaving permanent structural damage in people already cured of infection. Outcomes vary widely between individuals with comparable microbiological cure, and there is currently no way to predict who will develop fibrosis, prevent it, or treat its underlying biology. This scoping review mapped the evidence on host factors associated with variability in post-tuberculosis pulmonary fibrosis and related structural and functional sequelae. Methods Following PRISMA-ScR guidance, six databases were searched from inception to 31 August 2026. Studies of adults with treated pulmonary tuberculosis that examined host biological, molecular or clinical factors in relation to fibrotic, structural or functional outcomes were included. Two reviewers independently screened and appraised studies, and findings were charted against a predefined domain framework and an evidence gap map. Results Twenty studies were included, mostly observational and from high-burden settings. Evidence centred on clinical and radiological characterisation. Where biology was measured, persistent inflammation (IL-6, TNF-α) and matrix metalloproteinase activity were the most consistent signals associated with fibrotic and structural outcomes. Genetic, transcriptomic and metabolomic evidence was sparse, and no eligible study addressed epigenetic or microbiome factors. Conclusions Research on post-tuberculosis pulmonary fibrosis remains largely descriptive, and the critical gap is validated, targetable host biology. IL-6, TNF-α and matrix metalloproteinases are the strongest candidates and the priority for validation. Defining these pathways would open post-tuberculosis fibrosis to precision medicine, identifying survivors at risk early and treating them before irreversible damage is established.

Research Square
University of Liverpool (GB), Stockport NHS Foundation Trust (GB), Shrewsbury and Telford Hospital NHS Trust (GB)
Good health and well-being
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon